Stoke Therapeutics, Inc. SEC filings STOK
Stoke Therapeutics, Inc. has 632 filings in SEC EDGAR's recent list, going back to Nov 24, 2014. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 25, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Other events
|
Aug 3, 2026 | Aug 3, 2026 |
| 424B5 | Prospectus supplement | Aug 3, 2026 | — |
| S-8 | Employee stock plan registration | Aug 3, 2026 | — |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 7, 2026 | Apr 3, 2026 |
| 8-K |
Current report
Auditor change
|
Mar 27, 2026 | Mar 23, 2026 |
| S-3ASR | Automatic shelf registration | Mar 18, 2026 | — |
| S-8 | Employee stock plan registration | Mar 16, 2026 | — |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2026 | Feb 13, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 26, 2026 | Jan 21, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 12, 2026 | Jan 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2025 | Dec 5, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 6, 2025 | Oct 5, 2025 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Sep 18, 2025 | Jun 3, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2025 | Aug 11, 2025 |
| EFFECT | Filing | Jul 11, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 10, 2025 | Jul 10, 2025 |
| CORRESP | Letter to the SEC | Jul 9, 2025 | — |
| S-8 | Employee stock plan registration | Jul 9, 2025 | — |
| S-3 | Shelf registration | Jul 9, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2025 | — |
| DRSLTR | Filing | Jun 26, 2025 | — |
| DRS | Filing | Jun 26, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 4, 2025 | Jun 4, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 3, 2025 |
| S-8 | Employee stock plan registration | Mar 18, 2025 | — |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Feb 18, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 7, 2025 | Jan 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 6, 2024 | Dec 4, 2024 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| S-3ASR | Automatic shelf registration | Oct 9, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 10, 2024 | Sep 10, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2024 | Jun 18, 2024 |
| EFFECT | Filing | Jun 20, 2024 | — |
| CORRESP | Letter to the SEC | Jun 17, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2024 | — |
| S-3 | Shelf registration | Jun 13, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| 10-Q | Quarterly report | May 6, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2024 | Apr 29, 2024 |
| ARS | Annual report to shareholders | Apr 23, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Jun 5, 2024 |
| S-8 | Employee stock plan registration | Apr 11, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 28, 2024 | Mar 27, 2024 |
| 424B5 | Prospectus supplement | Mar 28, 2024 | — |
| FWP | Free writing prospectus | Mar 28, 2024 | — |
| 424B5 | Prospectus supplement | Mar 26, 2024 | — |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 25, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 14, 2023 | Dec 12, 2023 |
| SC TO-I/A | Filing | Dec 5, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 1, 2023 | Dec 1, 2023 |
| SC TO-I/A | Filing | Nov 17, 2023 | — |
| CORRESP | Letter to the SEC | Nov 17, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| SC TO-I/A | Filing | Nov 9, 2023 | — |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| SC TO-I | Filing | Nov 2, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 26, 2023 | Oct 24, 2023 |
| DEF 14A | Proxy statement | Sep 28, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2023 | Sep 19, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 18, 2023 | Sep 15, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 25, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2023 | Jun 13, 2023 |
| DEFA14A | Additional proxy material | May 24, 2023 | — |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 13, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2023 | Jun 13, 2023 |
| S-8 | Employee stock plan registration | Apr 13, 2023 | — |
| S-8 | Employee stock plan registration | Mar 22, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 15, 2023 | Mar 15, 2023 |
| 10-K | Annual report | Mar 6, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 3, 2023 | Feb 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 2, 2022 | Dec 2, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2022 | Jun 7, 2022 |
| EFFECT | Filing | May 31, 2022 | — |
| CORRESP | Letter to the SEC | May 26, 2022 | — |
| UPLOAD | Letter from the SEC | May 25, 2022 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
May 20, 2022 | May 20, 2022 |
| S-3 | Shelf registration | May 20, 2022 | — |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Jun 7, 2022 |
| S-8 | Employee stock plan registration | Mar 14, 2022 | — |
| 10-K | Annual report | Mar 10, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Listing notice
|
Feb 17, 2022 | Feb 11, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
|
Jan 10, 2022 | Jan 9, 2022 |
| 8-K | Current report | Dec 17, 2021 | Dec 14, 2021 |
| 8-K |
Current report
Other events
|
Dec 3, 2021 | Dec 3, 2021 |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2021 | Nov 8, 2021 |
| 8-K |
Current report
Other events
|
Sep 21, 2021 | Sep 21, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 9, 2021 | Sep 8, 2021 |
| 10-Q | Quarterly report | Aug 10, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2021 | Jun 8, 2021 |
| 10-Q/A | Amended quarterly report | May 14, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| DEFA14A | Additional proxy material | Apr 26, 2021 | — |
| DEF 14A | Proxy statement | Apr 26, 2021 | Jun 8, 2021 |
| S-8 | Employee stock plan registration | Mar 19, 2021 | — |
| 10-K | Annual report | Mar 9, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2021 | Mar 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 5, 2021 | Feb 5, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 20, 2020 | Nov 19, 2020 |
| 424B5 | Prospectus supplement | Nov 20, 2020 | — |
| 424B5 | Prospectus supplement | Nov 18, 2020 | — |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 12, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Other events
|
Oct 7, 2020 | Oct 7, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2020 | Aug 17, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 17, 2020 | Aug 13, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| EFFECT | Filing | Jul 20, 2020 | — |
| CORRESP | Letter to the SEC | Jul 16, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2020 | — |
| S-3 | Shelf registration | Jul 10, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 9, 2020 | Jul 9, 2020 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Jun 4, 2020 | Jun 3, 2020 |
| 10-Q | Quarterly report | May 15, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 15, 2020 | May 15, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 12, 2020 | May 12, 2020 |
| DEFA14A | Additional proxy material | Apr 21, 2020 | — |
| DEF 14A | Proxy statement | Apr 21, 2020 | Jun 3, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 15, 2020 | Apr 14, 2020 |
| S-8 | Employee stock plan registration | Mar 23, 2020 | — |
| 10-K | Annual report | Mar 23, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2020 | Mar 23, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 9, 2019 | Dec 7, 2019 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| 10-Q | Quarterly report | Aug 14, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2019 | Aug 14, 2019 |
| 424B4 | Prospectus | Jun 19, 2019 | — |
| S-8 | Employee stock plan registration | Jun 19, 2019 | — |
| EFFECT | Filing | Jun 18, 2019 | — |
| S-1MEF | Filing | Jun 18, 2019 | — |
| CORRESP | Letter to the SEC | Jun 14, 2019 | — |
| CORRESP | Letter to the SEC | Jun 14, 2019 | — |
| CERT | 8-a cert | Jun 13, 2019 | — |
| SEC STAFF LETTER | Filing | Jun 13, 2019 | — |
| CORRESP | Letter to the SEC | Jun 12, 2019 | — |
| S-1/A | Amended registration statement | Jun 12, 2019 | — |
| 8-A12B | Filing | Jun 11, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2019 | — |
| CORRESP | Letter to the SEC | Jun 7, 2019 | — |
| S-1/A | Amended registration statement | Jun 7, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2019 | — |
| SEC STAFF LETTER | Filing | Jun 3, 2019 | — |
| CORRESP | Letter to the SEC | Jun 3, 2019 | — |
| CORRESP | Letter to the SEC | May 23, 2019 | — |
| S-1 | Registration statement | May 23, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- STOK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bedford, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1623526
- Former names
- ASOthera Pharmaceuticals, Inc. (until Nov 24, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.